Alzheimer's & Dementia
Leukaemia drug linked to lower neurodegenerative disease risk
People starting nilotinib, a leukaemia drug, had a hazard ratio of 0.37 for neurodegenerative disease diagnosis or death versus matched people without chronic myeloid…People starting nilotinib, a leukaemia drug, had a hazard ratio of 0.37 for neurodegenerative disease diagnosis or death versus matched people without chronic myeloid leukaemia.
Cohort study of 1,322 peopleNeurodegenerative disease